Insider Trading activities of Aduro Biotech, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aduro Biotech, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aduro Biotech, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aduro Biotech, Inc. since 2005. The reporting company's ticker symbol is ADRO. The reporting company's CIK number is 1435049.
The total value of stock buying since 2005 is $12,940,264.
The total value of stock sales since 2005 is $24,466,821.
The total value of stock option exercises since 2005 is $1,441,590.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aduro Biotech, Inc. (ADRO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 76,600 $821,963 76,600 $51,312
2017-09 0 $0 117,025 $1,345,024 76,600 $53,112
2017-08 0 $0 146,600 $1,745,629 146,600 $127,611
2017-07 0 $0 112,000 $1,252,837 112,000 $59,969
2017-06 0 $0 244,301 $2,532,777 244,301 $167,835
2017-05 0 $0 43,631 $432,869 40,972 $21,304
2017-04 0 $0 35,273 $366,068 35,273 $17,781
2017-03 0 $0 60,273 $671,514 60,273 $38,531
2017-01 0 $0 64,058 $722,389 60,273 $30,781
2016-12 0 $0 156,819 $1,736,463 191,819 $133,493
2016-11 0 $0 150,271 $2,241,125 143,183 $163,751
2016-10 0 $0 52,273 $662,421 52,273 $38,806
2016-09 0 $0 31,360 $445,857 30,455 $29,098
2016-08 0 $0 25,000 $379,500 25,000 $24,625
2016-07 0 $0 25,000 $290,250 25,000 $24,625
2016-05 0 $0 2,715 $22,260 0 $0
2016-01 0 $0 87,242 $2,170,869 87,242 $124,948
2015-12 0 $0 110,242 $3,273,364 151,442 $220,952
2015-11 0 $0 119,122 $3,353,642 110,242 $113,056
2015-04 761,192 $12,940,264 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aduro Biotech, Inc. insiders (ADRO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-02 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 10,000 10.59 105,870
2017-10-02 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 10,000 .52 5,200
2017-10-02 Lew Jennifer (Sr. Vice President of Finance) Sale 6,600 10.61 69,993
2017-10-02 Lew Jennifer (Sr. Vice President of Finance) Option Ex 6,600 .82 5,412
2017-10-02 Isaacs Stephen T (President and CEO) Sale 40,000 10.78 431,040
2017-10-02 Isaacs Stephen T (President and CEO) Option Ex 40,000 .45 18,000
2017-10-02 Schafer Gregory W (Chief Operating Officer) Sale 20,000 10.75 215,060
2017-10-02 Schafer Gregory W (Chief Operating Officer) Option Ex 20,000 1.14 22,700
2017-09-18 Templeman Blaine (Executive VP, General Counsel) Sale 2,884 11.20 32,300
2017-09-13 Van Elsas Andrea (Chief Scientific Officer) Sale 4,922 10.99 54,073
2017-09-13 Templeman Blaine (Executive VP, General Counsel) Sale 3,557 10.99 39,077
2017-09-13 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 3,557 10.99 39,077
2017-09-13 Lew Jennifer (Sr. Vice President of Finance) Sale 3,557 10.99 39,077
2017-09-13 Isaacs Stephen T (President and CEO) Sale 12,204 10.99 134,073
2017-09-13 Schafer Gregory W (Chief Operating Officer) Sale 4,859 10.99 53,380
2017-09-01 Sacks Natalie (Chief Medical Officer) Sale 4,885 11.71 57,198
2017-09-01 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 10,000 11.70 116,950
2017-09-01 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 10,000 .52 5,200
2017-09-01 Lew Jennifer (Sr. Vice President of Finance) Sale 6,600 11.70 77,239
2017-09-01 Lew Jennifer (Sr. Vice President of Finance) Option Ex 6,600 .82 5,412
2017-09-01 Isaacs Stephen T (President and CEO) Sale 40,000 11.71 468,600
2017-09-01 Isaacs Stephen T (President and CEO) Option Ex 40,000 .45 18,000
2017-09-01 Schafer Gregory W (Chief Operating Officer) Sale 20,000 11.70 233,980
2017-09-01 Schafer Gregory W (Chief Operating Officer) Option Ex 20,000 1.23 24,500
2017-08-11 Dubensky Thomas W. (Chief Scientific Officer) Sale 9,088 11.17 101,540
2017-08-11 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 9,088 1.00 9,088
2017-08-10 Dubensky Thomas W. (Chief Scientific Officer) Sale 40,912 11.43 467,665
2017-08-10 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 40,912 1.00 40,912
2017-08-08 Schafer Gregory W (Chief Operating Officer) Sale 14,189 12.16 172,552
2017-08-08 Schafer Gregory W (Chief Operating Officer) Option Ex 14,189 1.23 17,381
2017-08-07 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 10,000 12.18 121,800
2017-08-07 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 10,000 .52 5,200
2017-08-07 Lew Jennifer (Sr. Vice President of Finance) Sale 6,600 12.16 80,289
2017-08-07 Lew Jennifer (Sr. Vice President of Finance) Option Ex 6,600 .82 5,412
2017-08-07 Isaacs Stephen T (President and CEO) Sale 40,000 12.19 487,560
2017-08-07 Isaacs Stephen T (President and CEO) Option Ex 40,000 .45 18,000
2017-08-07 Schafer Gregory W (Chief Operating Officer) Sale 25,811 12.17 314,223
2017-08-07 Schafer Gregory W (Chief Operating Officer) Option Ex 25,811 1.23 31,618
2017-07-06 Dubensky Thomas W. (Chief Scientific Officer) Sale 4,512 11.23 50,674
2017-07-06 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 4,512 .52 2,346
2017-07-05 Dubensky Thomas W. (Chief Scientific Officer) Sale 33,688 11.46 385,929
2017-07-05 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 33,688 .52 17,517
2017-07-05 Isaacs Stephen T (President and CEO) Sale 1,341 11.01 14,763
2017-07-03 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 10,000 11.02 110,170
2017-07-03 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 10,000 .47 4,730
2017-07-03 Dubensky Thomas W. (Chief Scientific Officer) Sale 11,800 11.02 130,024
2017-07-03 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 11,800 .52 6,136
2017-07-03 Lew Jennifer (Sr. Vice President of Finance) Sale 12,000 11.14 133,632
2017-07-03 Lew Jennifer (Sr. Vice President of Finance) Option Ex 12,000 .82 9,840
2017-07-03 Isaacs Stephen T (President and CEO) Sale 38,659 11.06 427,645
2017-07-03 Isaacs Stephen T (President and CEO) Option Ex 40,000 .48 19,400
2017-06-28 Lew Jennifer (Sr. Vice President of Finance) Sale 12,000 11.19 134,232
2017-06-28 Lew Jennifer (Sr. Vice President of Finance) Option Ex 12,000 .82 9,840
2017-06-28 Schafer Gregory W (Chief Operating Officer) Sale 40,000 11.26 450,560
2017-06-28 Schafer Gregory W (Chief Operating Officer) Option Ex 40,000 1.45 58,000
2017-06-19 Isaacs Stephen T (President and CEO) Sale 40,000 10.50 420,160
2017-06-19 Isaacs Stephen T (President and CEO) Option Ex 40,000 .52 20,800
2017-06-05 Dubensky Thomas W. (Chief Scientific Officer) Sale 17,577 9.99 175,629
2017-06-05 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 17,577 .52 9,140
2017-06-02 Dubensky Thomas W. (Chief Scientific Officer) Sale 48,753 10.10 492,307
2017-06-02 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 48,753 .52 25,351
2017-06-01 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 8,000 10.00 80,024
2017-06-01 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 8,000 .52 4,160
2017-06-01 Dubensky Thomas W. (Chief Scientific Officer) Sale 77,971 10.00 779,865
2017-06-01 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 77,971 .52 40,544
2017-05-17 Templeman Blaine (Executive VP, General Counsel) Sale 1,648 9.65 15,903
2017-05-17 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 1,011 9.65 9,756
2017-05-16 Isaacs Stephen T (President and CEO) Sale 16,673 10.00 166,796
2017-05-16 Isaacs Stephen T (President and CEO) Option Ex 16,673 .52 8,669
2017-05-15 Isaacs Stephen T (President and CEO) Sale 10,600 10.02 106,159
2017-05-15 Isaacs Stephen T (President and CEO) Option Ex 10,600 .52 5,512
2017-05-12 Dubensky Thomas W. (Chief Scientific Officer) Sale 4,299 9.92 42,658
2017-05-12 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 4,299 .52 2,235
2017-05-11 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 8,000 9.72 77,728
2017-05-11 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 8,000 .52 4,160
2017-05-11 Dubensky Thomas W. (Chief Scientific Officer) Sale 1,400 9.91 13,869
2017-05-11 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 1,400 .52 728
2017-04-03 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 8,000 10.71 85,648
2017-04-03 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 8,000 .45 3,600
2017-04-03 Isaacs Stephen T (President and CEO) Sale 27,273 10.28 280,420
2017-04-03 Isaacs Stephen T (President and CEO) Option Ex 27,273 .52 14,181
2017-03-13 Isaacs Stephen T (President and CEO) Sale 27,273 11.35 309,439
2017-03-13 Isaacs Stephen T (President and CEO) Option Ex 27,273 .52 14,181
2017-03-09 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 8,000 11.00 88,000
2017-03-09 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 8,000 .45 3,600
2017-03-09 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 10.96 274,075
2017-03-09 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .83 20,750
2017-01-17 Brockstedt Dirk G. (EVP of Research and Dev.) Sale 8,000 11.86 94,856
2017-01-17 Brockstedt Dirk G. (EVP of Research and Dev.) Option Ex 8,000 .45 3,600
2017-01-11 Templeman Blaine (Executive VP, General Counsel) Sale 3,785 11.95 45,230
2017-01-03 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 11.16 279,000
2017-01-03 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .52 13,000
2017-01-03 Isaacs Stephen T (President and CEO) Sale 27,273 11.12 303,303
2017-01-03 Isaacs Stephen T (President and CEO) Option Ex 27,273 .52 14,181
2016-12-23 Schafer Gregory W (Chief Operating Officer) Option Ex 35,000 .82 28,700
2016-12-01 Dubensky Thomas W. (Chief Scientific Officer) Sale 50,000 10.94 547,000
2016-12-01 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 50,000 .83 41,500
2016-12-01 Isaacs Stephen T (President and CEO) Sale 54,546 11.20 610,642
2016-12-01 Isaacs Stephen T (President and CEO) Option Ex 54,546 .52 28,362
2016-11-14 Haghighat Ross (Director) Sale 7,088 15.50 109,864
2016-11-14 Isaacs Stephen T (President and CEO) Sale 27,273 15.26 416,049
2016-11-14 Isaacs Stephen T (President and CEO) Option Ex 27,273 .52 14,181
2016-11-11 Schafer Gregory W (Chief Operating Officer) Sale 30,144 14.86 448,030
2016-11-11 Schafer Gregory W (Chief Operating Officer) Option Ex 30,144 1.45 43,708
2016-11-10 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 14.78 369,400
2016-11-10 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .98 24,625
2016-11-10 Lew Jennifer (Sr. Vice President of Finance) Sale 10,910 14.95 163,104
2016-11-10 Lew Jennifer (Sr. Vice President of Finance) Option Ex 10,910 .82 8,946
2016-11-10 Schafer Gregory W (Chief Operating Officer) Sale 49,856 14.74 734,678
2016-11-10 Schafer Gregory W (Chief Operating Officer) Option Ex 49,856 1.45 72,291
2016-10-03 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 12.68 316,900
2016-10-03 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .98 24,625
2016-10-03 Isaacs Stephen T (President and CEO) Sale 27,273 12.67 345,521
2016-10-03 Isaacs Stephen T (President and CEO) Option Ex 27,273 .52 14,181
2016-09-19 Lew Jennifer (Sr. Vice President of Finance) Sale 6,360 14.95 95,082
2016-09-19 Lew Jennifer (Sr. Vice President of Finance) Option Ex 5,455 .82 4,473
2016-09-01 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 14.03 350,775
2016-09-01 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .98 24,625
2016-08-11 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 15.18 379,500
2016-08-11 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .98 24,625
2016-07-05 Dubensky Thomas W. (Chief Scientific Officer) Sale 25,000 11.61 290,250
2016-07-05 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 25,000 .98 24,625
2016-05-16 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Sale 905 8.20 7,420
2016-05-16 Dubensky Thomas W. (Chief Scientific Officer) Sale 905 8.20 7,420
2016-05-16 Schafer Gregory W (Chief Operating Officer) Sale 905 8.20 7,420
2016-01-11 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Sale 22,000 22.69 499,224
2016-01-11 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Option Ex 22,000 .95 20,900
2016-01-08 Schafer Gregory W (Chief Operating Officer) Sale 20,000 23.58 471,599
2016-01-08 Schafer Gregory W (Chief Operating Officer) Option Ex 20,000 1.00 20,000
2016-01-06 Lew Jennifer (Sr. Vice President of Finance) Sale 5,242 25.86 135,584
2016-01-06 Lew Jennifer (Sr. Vice President of Finance) Option Ex 5,242 .82 4,298
2016-01-05 Isaacs Stephen T (President and CEO) Sale 12,500 26.52 331,562
2016-01-05 Isaacs Stephen T (President and CEO) Option Ex 12,500 .52 6,500
2016-01-04 Dubensky Thomas W. (Chief Scientific Officer) Sale 15,000 26.59 398,775
2016-01-04 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 15,000 4.45 66,750
2016-01-04 Isaacs Stephen T (President and CEO) Sale 12,500 26.73 334,125
2016-01-04 Isaacs Stephen T (President and CEO) Option Ex 12,500 .52 6,500
2015-12-31 Isaacs Stephen T (President and CEO) Option Ex 10,000 .45 4,500
2015-12-29 Lew Jennifer (Sr. Vice President of Finance) Option Ex 4,200 .82 3,444
2015-12-24 Schafer Gregory W (Chief Operating Officer) Option Ex 15,000 .82 12,300
2015-12-16 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Option Ex 12,000 1.45 17,400
2015-12-10 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Sale 25,000 29.75 743,750
2015-12-10 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Option Ex 25,000 1.45 36,250
2015-12-07 Schafer Gregory W (Chief Operating Officer) Sale 25,000 29.80 745,125
2015-12-07 Schafer Gregory W (Chief Operating Officer) Option Ex 25,000 1.45 36,250
2015-12-03 Lew Jennifer (Sr. Vice President of Finance) Sale 5,242 30.16 158,124
2015-12-03 Lew Jennifer (Sr. Vice President of Finance) Option Ex 5,242 .82 4,298
2015-12-01 Dubensky Thomas W. (Chief Scientific Officer) Sale 30,000 29.66 889,740
2015-12-01 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 30,000 3.12 93,510
2015-12-01 Isaacs Stephen T (President and CEO) Sale 25,000 29.46 736,625
2015-12-01 Isaacs Stephen T (President and CEO) Option Ex 25,000 .52 13,000
2015-11-30 Greenman William Mariner (Director) Sale 3,000 30.65 91,950
2015-11-18 Lew Jennifer (Sr. Vice President of Finance) Sale 6,712 28.52 191,426
2015-11-18 Lew Jennifer (Sr. Vice President of Finance) Option Ex 5,242 .82 4,298
2015-11-17 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Sale 19,047 28.27 538,458
2015-11-17 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Option Ex 19,047 .70 13,332
2015-11-17 Dubensky Thomas W. (Chief Scientific Officer) Sale 20,519 28.23 579,148
2015-11-17 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 20,519 1.45 29,752
2015-11-17 Schafer Gregory W (Chief Operating Officer) Sale 15,178 28.31 429,689
2015-11-17 Schafer Gregory W (Chief Operating Officer) Option Ex 15,178 1.45 22,008
2015-11-16 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Sale 7,423 27.55 204,540
2015-11-16 Brockstedt Dirk G. (Sr. VP of Research and Dev.) Option Ex 5,953 .45 2,678
2015-11-16 Dubensky Thomas W. (Chief Scientific Officer) Sale 10,951 27.78 304,185
2015-11-16 Dubensky Thomas W. (Chief Scientific Officer) Option Ex 9,481 1.45 13,747
2015-11-16 Isaacs Stephen T (President and CEO) Sale 25,000 28.01 700,250
2015-11-16 Isaacs Stephen T (President and CEO) Option Ex 25,000 .52 13,000
2015-11-16 Schafer Gregory W (Chief Operating Officer) Sale 11,292 27.81 313,996
2015-11-16 Schafer Gregory W (Chief Operating Officer) Option Ex 9,822 1.45 14,241
2015-04-20 Morningside Venture (vi) Investments Ltd (10% Owner) Buy 441,176 17.00 7,499,992
2015-04-20 Obrien Stephanie Monaghan (Director) Buy 3,400 17.00 57,800
2015-04-20 Rogers John E. And Lois A. (10% Owner) Buy 164,558 17.00 2,797,486
2015-04-20 Lew Jennifer (Sr. Vice President of Finance) Buy 2,000 17.00 34,000
2015-04-20 Greenman William Mariner (Director) Buy 3,000 17.00 51,000

Insider trading activities including stock purchases, stock sales, and option exercises of ADRO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aduro Biotech, Inc. (symbol ADRO, CIK number 1435049) see the Securities and Exchange Commission (SEC) website.